Inventor · disambiguated record
Elliott Richelson
Also filed as: RICHELSON ELLIOTT
19 granted patents·21 pending applications·210 citations·filing 1997–2014
95Inventor score
Files withMAYO FOUNDATION16RICHELSON ELLIOTT11BARBUT DENISE5SARENTIS THERAPEUTICS INC3VIRGINIA TECH INTELL PROP2
Top patents by PatentIndex Score
40 records- 0193US6214790B1Neo-tryptophanMAYO FOUNDATION·Filed 1999·Granted Apr 10, 2001·73 cites·66 claims
- 0290US7671025B2Neurotensin receptor agonists and opioid receptor agonistsSARENTIS THERAPEUTICS INC·Filed 2007·Granted Mar 2, 2010·11 cites·3 claims
- 0389US6921805B2Neo-tryptophanMAYO FOUNDATION·Filed 2004·Granted Jul 26, 2005·13 cites·2 claims
- 0488US7214826B2Amine compounds and inhibiting neurotransmitter reuptakeVIRGINIA TECH INTELL PROP·Filed 2005·Granted May 8, 2007·8 cites·5 claims
- 0588US7098307B2Neo-tryptophanMAYO FOUNDATION·Filed 2005·Granted Aug 29, 2006·8 cites·8 claims
- 0686US6765099B2Neo-tryptophanMAYO FOUNDATION·Filed 2002·Granted Jul 20, 2004·12 cites·2 claims
- 0785US8058230B2Neurotensin receptor agonists and opioid receptor agonistsBARBUT DENISE·Filed 2010·Granted Nov 15, 2011·6 cites·10 claims
- 0885US7642231B2Neo-tryptophanMAYO FOUNDATION·Filed 2006·Granted Jan 5, 2010·3 cites·8 claims
- 0985US6700018B2Amine compounds and inhibiting neurotransmitter reuptakeMAYO FOUNDATION·Filed 2001·Granted Mar 2, 2004·11 cites·5 claims
- 1082US6914080B2Amine compounds and inhibiting neurotransmitter reuptakeVIRGINIA TECH INTELL PROP·Filed 2004·Granted Jul 5, 2005·8 cites·3 claims
- 1181US8440724B2Inhibiting neurotransmitter reuptakeRICHELSON ELLIOTT·Filed 2009·Granted May 14, 2013·2 cites·9 claims
- 1275US6069177A3-Hydroxy-propanamine derived neuronal reuptake inhibitorsUNIV HONG KONG SCIENCE & TECHN·Filed 1997·Granted May 30, 2000·34 cites·12 claims
- 1374US2008261893A1Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healingBARBUT DENISE·Filed 2008·Application pending·0 cites
- 1469US2015273011A1Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healingSARENTIS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1568US8507500B2Inhibiting neurotransmitter reuptakeRICHELSON ELLIOTT·Filed 2012·Granted Aug 13, 2013·1 cites·17 claims
- 1668US2007197662A1Amine compounds and inhibiting neurotransmitter reuptakeRICHELSON ELLIOTT·Filed 2007·Application pending·0 cites
- 1767US2015080314A1Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healingSARENTIS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1863US2012208766A1Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healingBARBUT DENISE·Filed 2011·Application pending·0 cites
- 1963US2012207789A1Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healingBARBUT DENISE·Filed 2011·Application pending·0 cites
- 2061US2011183885A1Neo-tryptophanMAYO FOUNDATION·Filed 2011·Application pending·0 cites
- 2161US2012108519A1Neo-tryptophanRICHELSON ELLIOTT·Filed 2011·Application pending·0 cites
- 2260US2008275272A1Amine compounds and inhibiting neurotransmitter reuptakeRICHELSON ELLIOTT·Filed 2008·Application pending·0 cites
- 2359US2013210740A1Neo-tryptophanRICHELSON ELLIOTT·Filed 2012·Application pending·0 cites
- 2459US2006189536A1Treating the effects of nicotineMAYO FOUNDATION·Filed 2006·Application pending·0 cites
- 2557US2010173849A1Neo-tryptophanRICHELSON ELLIOTT·Filed 2010·Application pending·0 cites
- 2657US2001027174A1Neo-tryptophanMAYO FOUNDATION·Filed 2001·Application pending·0 cites
- 2756US7087575B2Treating the effect of nicotineMAYO FOUNDATION·Filed 2002·Granted Aug 8, 2006·0 cites·3 claims
- 2856US2004224889A1Using polyamide nucleic acid oligomers to engender a biological responseMAYO FOUNDATION·Filed 2004·Application pending·0 cites
- 2955US2009062212A1Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2RICHELSON ELLIOTT·Filed 2007·Application pending·0 cites
- 3053US6472209B1Using polyamide nucleic acid oligomers to engender a biological responseMAYO FOUNDATION·Filed 1997·Granted Oct 29, 2002·9 cites·52 claims
- 3152US2012058951A1Neurotensin receptor agonists and opioid receptor agonistsBARBUT DENISE·Filed 2011·Application pending·0 cites
- 3251US6723560B2Using polyamide nucleic acid oligomers to engender a biological responseMAYO FOUNDATION·Filed 1998·Granted Apr 20, 2004·6 cites·43 claims
- 3351US2011263507A1Peptide analogs that are potent and selective for human neurotensin receptor subtype 2RICHELSON ELLIOTT·Filed 2011·Application pending·0 cites
- 3451US2010168246A1Amine compounds and inhibiting neurotransmitter reuptakeRICHELSON ELLIOTT·Filed 2010·Application pending·0 cites
- 3549US9944618B2Inhibiting neurotransmitter reuptakeMAYO FOUND MEDICAL EDUCATION & RES·Filed 2014·Granted Apr 17, 2018·0 cites·10 claims
- 3647US2004009899A1Treating dominant disordersMCMURRAY CYNTHIA T·Filed 2002·Application pending·0 cites
- 3742US6743627B1Using polyamide nucleic acid oligomers to engender a biological responseMAYO FOUNDATION·Filed 1998·Granted Jun 1, 2004·4 cites·38 claims
- 3841US2012220665A1Inhibiting Neurotransmitter ReuptakeRICHELSON ELLIOTT·Filed 2010·Application pending·0 cites
- 3941US2008200556A1Amine Compounds And Inhibiting Neurotrasmitter ReuptakeMAYO FOUNDATION·Filed 2005·Application pending·0 cites
- 4032US6989270B1Using polyamide nucleic acid oligomers to engender a biological responseMAYO FOUNDATION·Filed 1998·Granted Jan 24, 2006·1 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Elliott Richelson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →